--- title: "12 Health Care Stocks Moving In Tuesday's Pre-Market Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/275456188.md" description: "In Tuesday's pre-market session, several health care stocks experienced significant movements. Gainers included Abpro Holdings (ABP) with a 90.1% rise to $2.89, Quince Therapeutics (QNCX) up 65.53% to $0.22, and Phio Pharma (PHIO) increasing 23.33% to $1.11. Conversely, Barinthus Biotherapeutics (BRNS) saw a sharp decline of 61.8% to $0.27, while Tectonic Therapeutic (TECX) fell 42.82% to $14.2. Other notable losers included Becton Dickinson (BDX), down 19.48% to $167.0, following Q1 earnings release." datetime: "2026-02-10T12:05:40.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275456188.md) - [en](https://longbridge.com/en/news/275456188.md) - [zh-HK](https://longbridge.com/zh-HK/news/275456188.md) generator: "portal-rs" --- # 12 Health Care Stocks Moving In Tuesday's Pre-Market Session ### Gainers - **Abpro Hldgs** (NASDAQ:ABP) stock rose 90.1% to $2.89 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.1 million. - **Quince Therapeutics** (NASDAQ:QNCX) stock rose 65.53% to $0.22. The company's market cap stands at $7.2 million. - **Phio Pharma** (NASDAQ:PHIO) shares rose 23.33% to $1.11. The company's market cap stands at $9.6 million. - **Microbot Medical** (NASDAQ:MBOT) shares increased by 16.3% to $2.14. The company's market cap stands at $123.5 million. - **Liminatus Pharma** (NASDAQ:LIMN) stock moved upwards by 13.1% to $1.64. The market value of their outstanding shares is at $39.2 million. - **Biomerica** (NASDAQ:BMRA) shares moved upwards by 10.59% to $2.4. The company's market cap stands at $6.5 million. ### Losers - **Barinthus Biotherapeutics** (NASDAQ:BRNS) shares fell 61.8% to $0.27 during Tuesday's pre-market session. The market value of their outstanding shares is at $28.8 million. - **Tectonic Therapeutic** (NASDAQ:TECX) shares decreased by 42.82% to $14.2. The company's market cap stands at $464.7 million. - **Ensysce Biosciences** (NASDAQ:ENSC) shares declined by 24.17% to $0.46. The company's market cap stands at $2.1 million. - **Becton Dickinson** (NYSE:BDX) shares fell 19.48% to $167.0. The company's market cap stands at $59.0 billion. As per the press release, Q1 earnings came out yesterday. - **Silexion Therapeutics** (NASDAQ:SLXN) stock declined by 16.58% to $1.46. The company's market cap stands at $5.4 million. - **CollPlant Biotechnologies** (NASDAQ:CLGN) shares fell 13.09% to $0.56. The market value of their outstanding shares is at $8.2 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [IHI.US](https://longbridge.com/en/quote/IHI.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [QNCX.US](https://longbridge.com/en/quote/QNCX.US.md) - [PHIO.US](https://longbridge.com/en/quote/PHIO.US.md) - [BDX.US](https://longbridge.com/en/quote/BDX.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md) - [XHE.US](https://longbridge.com/en/quote/XHE.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [ABP.US](https://longbridge.com/en/quote/ABP.US.md) - [ABPO.US](https://longbridge.com/en/quote/ABPO.US.md) ## Related News & Research - [What's Going On With Becton Dickinson Stock Wednesday?](https://longbridge.com/en/news/296385596.md) - [Phio Pharmaceuticals (NASDAQ:PHIO) Director Ronald Todd Plott Buys 15,000 Shares of Stock](https://longbridge.com/en/news/296616090.md) - [Phio Pharmaceuticals CEO Robert J. Bitterman reports purchase of $10,600 in common shares](https://longbridge.com/en/news/296394316.md) - [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md) - [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**